𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Risk factors for executive dysfunction after subthalamic nucleus stimulation in Parkinson's disease

✍ Scribed by Christine Daniels; Paul Krack; Jens Volkmann; Markus O. Pinsker; Martin Krause; Volker Tronnier; Manja Kloss; Alfons Schnitzler; Lars Wojtecki; Kai Bötzel; Adrian Danek; Rüdiger Hilker; Volker Sturm; Andreas Kupsch; Elfriede Karner; Günther Deuschl; Karsten Witt


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
144 KB
Volume
25
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

A slight decline in cognitive functions and especially in executive functioning after deep brain stimulation (DBS) of the nucleus subthalamicus (STN) in patients with Parkinson's disease (PD) has been described. This study evaluated baseline parameters that contribute to a deterioration of cognitive functioning after DBS. We analyzed data from the neuropsychological protocol in a randomized controlled study comparing DBS with best medical treatment (BMT). Change scores were calculated for the cognitive domains “global cognitive functioning,” “memory,” “working memory,” “attention,” and “executive function.” These domain‐specific change scores were correlated with previously defined preoperative parameters. Compared with the BMT group (63 patients), the STN‐DBS group (60 patients) showed a significant decline only in the domain executive function 6 months after DBS, which was significantly correlated with age, levodopa‐equivalence dosage (LED) and axial subscore of the UPDRS in the off‐medication state at baseline. Multiple regression analysis showed that these three factors explained, however, only about 23% of the variance. Patients with higher age, higher baseline LED, and/or higher axial subscore of the UPDRS at baseline have an increased risk for worsening of executive function after STN‐DBS. High scores of these factors might reflect an advanced stage of disease progression. As these baseline factors explained the variance of the change score executive function only to a minor proportion, other factors including the surgical procedure, the exact placement of the electrode or postsurgical management might be more relevant for a decline in executive functioning after STN‐DBS. © 2010 Movement Disorder Society


📜 SIMILAR VOLUMES


Bilateral subthalamic nucleus stimulatio
✍ Dr. Patricia Limousin; Pierre Pollak; Abdelhamid Benazzouz; Dominique Hoffmann; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB

## Abstract Subthalamic nucleus (STN) lesions or high‐frequency stimulations could improve parkinsonian symptoms in monkeys treated by MPTP. We have applied the procedure of chronic stimulation to the STN in severely disabled parkinsonian patients. This article presents the case of the first patien

Postoperative gait deterioration after b
✍ Bart F.L. van Nuenen; Rianne A.J. Esselink; Marten Munneke; Johhannes D. Speelma 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

## Abstract Deep brain stimulation of the subthalamic nuclei (STN) is a good therapeutic option to reduce dyskinesias and improve appendicular motor signs in well‐selected patients with advanced Parkinson's disease (PD). Concerns about long‐term adverse effects play an increasingly role in the deci

Postoperative management of subthalamic
✍ Paul Krack; Valérie Fraix; Alexandre Mendes; Alim-Louis Benabid; Pierre Pollak 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

The postoperative neurologic management of patients with deep brain stimulation (DBS) of the subthalamic nucleus (STN) for Parkinson' s disease is a complex dynamic process that involves a progressive increase in stimulation intensity and a parallel decrease in antiparkinsonian medication while asse

Subthalamic nucleus stimulation restores
✍ Monika Pötter-Nerger; Tihomir V. Ilic; Hartwiq R. Siebner; Günther Deuschl; Jens 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

## Abstract We have previously shown that in patients with Parkinson's disease (PD), high‐frequency stimulation (HFS) of the subthalamic nucleus (STN) modifies spinal excitability via subcortical reticulospinal routes. To investigate whether STN‐HFS also modifies spinal excitability via transcortic

Depression leading to attempted suicide
✍ Paresh K. Doshi; Niraj Chhaya; Mohit H. Bhatt 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 394 KB

## Abstract Subthalamic nucleus stimulation is emerging as an effective surgical therapy for Parkinson's disease. It is considered to be a safe procedure with little morbidity, the most common complications being intracranial haemorrhage and hardware failure. We report on three cases of depression,

Subthalamic nucleus deep brain stimulati
✍ Michelle R. Ciucci; Julie M. Barkmeier-Kraemer; Scott J. Sherman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

## Abstract Relatively little is known about the role of the basal ganglia in human deglutition. Deep brain stimulation (DBS) affords us a model for examining deglutition in humans with known impairment of the basal ganglia. The purpose of this study was to examine the effects of subthalamic nuclei